相似文献
1
Protein Kinase CK2: An Emerging Regulator of Immunity.
Trends Immunol. 2018 Feb;39(2):82-85. doi: 10.1016/j.it.2017.12.002. Epub 2018 Jan 4.
2
Protein Kinase CK2 Controls the Fate between Th17 Cell and Regulatory T Cell Differentiation.
J Immunol. 2017 Jun 1;198(11):4244-4254. doi: 10.4049/jimmunol.1601912. Epub 2017 May 3.
3
Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.
Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):10145-50. doi: 10.1073/pnas.1523869113. Epub 2016 Aug 23.
4
Casein kinase 2 is a critical determinant of the balance of Th17 and Treg cell differentiation.
Exp Mol Med. 2017 Sep 8;49(9):e375. doi: 10.1038/emm.2017.132.
5
Casein Kinase II exacerbates rheumatoid arthritis via promoting Th1 and Th17 cell inflammatory responses.
Expert Opin Ther Targets. 2021 Nov;25(11):1017-1024. doi: 10.1080/14728222.2021.2010190. Epub 2021 Dec 16.
6
Modulation of the CCR6-CCL20 Axis: A Potential Therapeutic Target in Inflammation and Cancer.
Medicina (Kaunas). 2018 Nov 16;54(5):88. doi: 10.3390/medicina54050088.
7
Th17 and regulatory T cell balance in autoimmune and inflammatory diseases.
Autoimmun Rev. 2014 Jun;13(6):668-77. doi: 10.1016/j.autrev.2013.12.004. Epub 2014 Jan 11.
8
CK2 Controls Th17 and Regulatory T Cell Differentiation Through Inhibition of FoxO1.
J Immunol. 2018 Jul 15;201(2):383-392. doi: 10.4049/jimmunol.1701592. Epub 2018 Jun 11.
9
Protein Kinase CK2 Maintains Reciprocal Balance Between Th17 and Treg Cells in the Pathogenesis of UC.
Inflamm Bowel Dis. 2022 Jun 3;28(6):830-842. doi: 10.1093/ibd/izab312.
10
Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.
Adv Biol Regul. 2017 Jan;63:71-80. doi: 10.1016/j.jbior.2016.09.003. Epub 2016 Sep 18.
引用本文的文献
1
CK2α Deletion in the Hematopoietic Compartment Shows a Mild Alteration in Terminally Differentiated Cells and the Expansion of Stem Cells.
Cells. 2025 Jun 24;14(13):963. doi: 10.3390/cells14130963.
2
CK2 regulates somatostatin expression in pancreatic delta cells.
Islets. 2025 Dec;17(1):2515332. doi: 10.1080/19382014.2025.2515332. Epub 2025 Jun 5.
3
RNAi library screening reveals Gβ1, Casein Kinase 2 and ICAP-1 as novel regulators of LFA-1-mediated T cell polarity and migration.
Immunol Cell Biol. 2025 Jan;103(1):73-92. doi: 10.1111/imcb.12838. Epub 2024 Nov 28.
4
A guide to selecting high-performing antibodies for CSNK2A1 (UniProt ID: P68400) for use in western blot, immunoprecipitation and immunofluorescence.
F1000Res. 2024 Sep 5;13:781. doi: 10.12688/f1000research.153243.2. eCollection 2024.
5
Serine/Threonine Protein Kinases as Attractive Targets for Anti-Cancer Drugs-An Innovative Approach to Ligand Tuning Using Combined Quantum Chemical Calculations, Molecular Docking, Molecular Dynamic Simulations, and Network-like Similarity Graphs.
Molecules. 2024 Jul 5;29(13):3199. doi: 10.3390/molecules29133199.
6
Revealing the Complete Bispecific Phosphatase Genes (DUSPs) across the Genome and Investigating the Expression Patterns of GH_A11G3500 Resistance against .
Int J Mol Sci. 2024 Apr 19;25(8):4500. doi: 10.3390/ijms25084500.
7
Influence of CK2 protein kinase activity on the interaction between Trypanosoma cruzi and its vertebrate and invertebrate hosts.
Parasitol Res. 2024 Jan 2;123(1):80. doi: 10.1007/s00436-023-08085-x.
8
Formulation and Investigation of CK2 Inhibitor-Loaded Alginate Microbeads with Different Excipients.
Pharmaceutics. 2023 Nov 29;15(12):2701. doi: 10.3390/pharmaceutics15122701.
9
The dual face of microglia (M1/M2) as a potential target in the protective effect of nutraceuticals against neurodegenerative diseases.
Front Aging. 2023 Sep 6;4:1231706. doi: 10.3389/fragi.2023.1231706. eCollection 2023.
10
An approach to identify early damage biomarker candidates in metachromatic leukodystrophy.
Mol Genet Metab Rep. 2023 May 15;35:100974. doi: 10.1016/j.ymgmr.2023.100974. eCollection 2023 Jun.
本文引用的文献
1
Protein Kinase CK2 Controls the Fate between Th17 Cell and Regulatory T Cell Differentiation.
J Immunol. 2017 Jun 1;198(11):4244-4254. doi: 10.4049/jimmunol.1601912. Epub 2017 May 3.
2
Protein Kinase CK2: Intricate Relationships within Regulatory Cellular Networks.
Pharmaceuticals (Basel). 2017 Mar 5;10(1):27. doi: 10.3390/ph10010027.
3
CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.
Pharmaceuticals (Basel). 2017 Jan 28;10(1):18. doi: 10.3390/ph10010018.
4
Protein kinase CK2 controls T-cell polarization through dendritic cell activation in response to contact sensitizers.
J Leukoc Biol. 2017 Mar;101(3):703-715. doi: 10.1189/jlb.3A0715-320RR. Epub 2016 Oct 5.
5
Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.
Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):10145-50. doi: 10.1073/pnas.1523869113. Epub 2016 Aug 23.
6
Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo.
Nat Immunol. 2015 Mar;16(3):267-75. doi: 10.1038/ni.3083. Epub 2015 Jan 19.
7
CD5-dependent CK2 activation pathway regulates threshold for T cell anergy.
J Immunol. 2012 Sep 15;189(6):2918-30. doi: 10.4049/jimmunol.1200065. Epub 2012 Aug 17.
8
Protein kinase CK2 is a critical regulator of epithelial homeostasis in chronic intestinal inflammation.
Mucosal Immunol. 2013 Jan;6(1):136-45. doi: 10.1038/mi.2012.57. Epub 2012 Jul 4.
9
Dynamic protein associations define two phases of IL-1beta transcriptional activation.
J Immunol. 2008 Jul 1;181(1):503-12. doi: 10.4049/jimmunol.181.1.503.
10
The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development.
Mol Cell Biol. 2008 Jan;28(1):131-9. doi: 10.1128/MCB.01119-07. Epub 2007 Oct 22.
Zotero 插件